{"id":"https://openalex.org/W2520022414","doi":"https://doi.org/10.5414/cp202727","title":"Pharmacokinetic profile of extended-release versus immediate-release oral naproxen sodium after single and multiple dosing under fed and fasting conditions: two randomized, open-label trials","display_name":"Pharmacokinetic profile of extended-release versus immediate-release oral naproxen sodium after single and multiple dosing under fed and fasting conditions: two randomized, open-label trials","publication_year":2016,"publication_date":"2016-09-17","ids":{"openalex":"https://openalex.org/W2520022414","doi":"https://doi.org/10.5414/cp202727","mag":"2520022414","pmid":"https://pubmed.ncbi.nlm.nih.gov/27639137"},"language":"en","primary_location":{"id":"doi:10.5414/cp202727","doi":"https://doi.org/10.5414/cp202727","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp202727","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053195722","display_name":"Irene Laurora","orcid":"https://orcid.org/0000-0003-1316-9318","observed_orcids":["https://orcid.org/0000-0003-1316-9318"]},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene Laurora","raw_affiliation_strings":["Bayer Consumer Health, Whippany, NJ and Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Consumer Health, Whippany, NJ and Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5115592911","display_name":"Yuan Wang","orcid":"https://orcid.org/0009-0009-7068-8684","observed_orcids":["https://orcid.org/0009-0009-7068-8684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuan Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1898,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.50024856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"54","issue":"10","first_page":"750","last_page":"760"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.4494999945163727,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2538999915122986,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.05869999900460243,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naproxen-sodium","display_name":"naproxen sodium","score":0.9480000138282776},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/immediate-release-formulation","display_name":"immediate-release formulation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9539999961853027},{"id":"https://openalex.org/keywords/fed-versus-fasted-state","display_name":"fed versus fasted state","score":0.6610000133514404},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.5899999737739563},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.5400000214576721},{"id":"https://openalex.org/keywords/absorption-rate","display_name":"absorption rate","score":0.6949999928474426},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.7630000114440918},{"id":"https://openalex.org/keywords/over-the-counter-analgesics","display_name":"over-the-counter analgesics","score":0.6370000243186951},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.9586754441261292},{"id":"https://openalex.org/C2909752691","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen Sodium","level":4,"score":0.9417544007301331},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7677434086799622},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7069214582443237},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5351378321647644},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.5341922640800476},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4990088939666748},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4539085328578949},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33677610754966736},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.05596610903739929},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cp202727","doi":"https://doi.org/10.5414/cp202727","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp202727","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:27639137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27639137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088451344","https://openalex.org/W2084446285","https://openalex.org/W2138191124","https://openalex.org/W2159448729","https://openalex.org/W2407286082","https://openalex.org/W2094436923","https://openalex.org/W2022891865","https://openalex.org/W139265385","https://openalex.org/W2418996057","https://openalex.org/W161339812"],"abstract_inverted_index":{"PURPOSE:":[0],"Extended-release":[1],"(ER)":[2],"naproxen":[3,33,54,62,112,119,124,150,153,165,173,181],"sodium":[4,34,55,63,120,125,154,174,182],"provides":[5],"pain":[6],"relief":[7],"for":[8,101],"up":[9],"to":[10,29,52,163,179],"24":[11],"hours":[12,76],"with":[13,117,122,146,158],"a":[14,130,143,159,200],"single":[15,23,201],"dose":[16,194,198],"(660":[17,175],"mg/day).":[18],"Its":[19],"pharmacokinetic":[20,80],"profile":[21,162],"after":[22,82,91,142],"and":[24,43,87,106,203],"multiple":[25,205],"dosing":[26],"was":[27,99,155],"compared":[28],"immediate":[30],"release":[31],"(IR)":[32],"in":[35],"two":[36],"randomized,":[37],"open-label,":[38],"crossover":[39],"studies,":[40],"under":[41,104,213],"fasting":[42,105],"fed":[44,107,214],"conditions.":[45,108,215],"METHODS:":[46],"Eligible":[47],"healthy":[48],"subjects":[49],"were":[50,114,127,138],"randomized":[51],"ER":[53,118,147,152,172],"660-mg":[56,196],"tablet":[57,65],"once":[58],"daily":[59,67,197],"or":[60],"IR":[61,123,149,164,180],"220-mg":[64],"twice":[66],"(440":[68],"mg":[69,74],"initially,":[70],"followed":[71],"by":[72],"220":[73],"12":[75],"later).":[77],"Primary":[78],"variables:":[79],"parameters":[81],"singleday":[83],"administration":[84,93],"(day":[85,94],"1)":[86],"at":[88,129,187],"steady":[89],"state":[90],"multiple-day":[92],"6).":[95],"RESULTS:":[96],"Total":[97],"exposure":[98,170],"comparable":[100,139,178],"both":[102],"treatments":[103],"After":[109],"fasting:":[110],"peak":[111,136],"concentrations":[113,137],"slightly":[115],"lower":[116],"than":[121],"but":[126,140],"reached":[128,141],"similar":[131,160],"time.":[132],"Fed":[133],"conditions:":[134],"mean":[135],"longer":[144],"time":[145],"vs.":[148],"sodium.":[151,166],"well":[156],"tolerated,":[157],"safety":[161],"CONCLUSIONS:":[167],"The":[168,207],"total":[169],"of":[171,195,209],"mg)":[176,184],"is":[177,211],"(220":[183],"when":[185],"administered":[186],"the":[188,191],"maximum":[189],"over":[190,204],"counter":[192],"(OTC)":[193],"on":[199],"day":[202],"days.":[206],"rate":[208],"absorption":[210],"delayed":[212]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-09-23T00:00:00"}